Panaxydol enhances the expression and secretion of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in Schwann cells (SCs), improving SC viability and biological characteristics, effectively protecting neurons from degenerative disease damage (He et al., 2009). The gene discussed is NGF; the disease is neurodegenerative disease.